Results 131 to 140 of about 44,168 (180)
Organizational impacts of fixed-duration therapies for the management of patients with chronic lymphocytic leukemia in Italy. [PDF]
Rognoni C +6 more
europepmc +1 more source
Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study. [PDF]
Coste A +25 more
europepmc +1 more source
A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion. [PDF]
Majid D +17 more
europepmc +1 more source
[Analysis of the efficacy of half-dose venetoclax combined with reduced-dose HA regimen in the induction therapy of acute myeloid leukemia]. [PDF]
Yan ZS +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:

